Open Access Open Access  Restricted Access Subscription Access

Letter to the editor

Erik Heegaard, MD, PhD, DMSc, Martin B. Oleksiewicz, DVM, PhD, Nina R. Steenhard, DVM, PhD, John-Erik S. Hansen, MD, DMSc

Abstract


Modernizing smallpox vaccine stockpiles

 

Authors’ response




Keywords


vaccine stockpiles, disaster medicine

Full Text:

PDF

References


Oleksiewicz M, Steenhard NR, Hansen JES: Modernizing stockpiles of medical countermeasures against smallpox: Benefits, risks, and knowledge gaps. Am J Dis Med. 2015; 10(2): 109-120.

Gaudioso JM, Brooks T, Furukawa K, et al.: Likelihood of Smallpox Recurrence. Journal of Bioterrorism and Biodefense. 2011; 2(2): 1-7.

L'vov DK, Zverev VV, Gintsburg AL, et al.: [Smallpox is a dormant volcano]. Vopr Virusol. 2008; 53(4):4-8.

Phillips KE: Climate threat: thawing tundra releases infected corpses. Available at www.livescience.com/environment/080327-smallpox-corpses.html. Accessed April 7, 2016.

Tucker.J: The smallpox destruction debate: could a grand bargain settle the issue? Available at www.armscontrol.org/act/2009_03/tucker. Accessed April 7, 2016.

Century-old smallpox scabs discovered. Available at: http://www.thefreelibrary.com/Century-old+small pox+scabs+discovered.-a0114339157. Accessed April 7, 2016.

Wolff HL, Croon JJ: The survival of smallpox virus (variola minor) in natural circumstances. Bull World Health Organ. 1968; 38(3):492-493.

Jackson RJ, Ramsay AJ, Christensen CD, et al.: Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol. 2001; 75(3): 1205-1210.

Shchelkunov SN, Totmenin AV, Babkin IV, et al.: Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett. 2001; 509(1): 66-70.

Cello J, Paul AV, Wimmer E: Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science. 2002; 297(5583): 1016-1018.

Smith HO, Hutchison CA, Pfannkoch C, et al.: Generating a synthetic genome by whole genome assembly: phiX174 bacteriophage from synthetic oligonucleotides. Proc Natl Acad Sci USA. 2003; 100(26): 15440-15445.

Tumpey TM, Basler CF, Aguilar PV, et al.: Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science. 2005; 310(5745): 77-80.

Enterlein S, Volchkov V, Weik M, et al.: Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30. J Virol. 2006; 80(2): 1038-1043.

Becker MM, Graham RL, Donaldson EF, et al.: Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc Natl Acad Sci USA. 2008; 105(50): 19944-19949.

Gibson DG, Benders GA, Andrews-Pfannkoch C, et al.: Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science. 2008; 319(5867): 1215-1220.

Gibson DG, Glass JI, Lartigue C., et al.: Creation of a bacterial cell controlled by a chemically synthesized genome. Science. 2010; 329(5987): 52-56.

Mitchell E, O'Mahony M, Watson JM, et al.: Two outbreaks of legionnaires' disease in Bolton Health District. Epidemiol Infect. 1990; 104(2): 159-170.

Final report on potential breaches of biosecurity at the Pirbright site 2007. Available at http://news.bbc.co.uk/1/shared/bsp/hi/pdfs/07_09_07finalreporthsefandm.pdf. Accessed April 7, 2016.

Miller J: Russian Scientist Dies in Ebola Accident at Former Weapons Lab. The New York Times. May 25, 2004. Available at http://www.nytimes.com/2004/05/25/world/russian-scientistdies-in-ebola-accident-at-former-weapons-lab.html. Accessed April 7, 2016.

Canadian-made ebola vaccine used after German lab accident. The Canadian Press. Mar 20, 2009. Available at: http://www.cbc.ca/news/technology/canadian-made-ebola-vaccine-usedafter-german-lab-accident-1.827949. Accessed April 7, 2016.

Kortepeter MG, Martin JW, Rusnak JM, et al.: Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit. Emerg Infect Dis. 2008; 14(6): 881-887.

Author’s reply:

Heegaard E: Letter to the editor, regarding publication on modernizing stockpiles of medical countermeasures against smallpox. Am. J. Disaster Med. 2016; 9(4): PP-PP.

Gaudioso J, Brooks T, Furukawa K, et al: Likelihood of Smallpox Recurrence. J. Bioterr. Biodef. 2011; 2: 106.

Oleksiewicz MB, Steenhard NR, Hansen JE: Modernizing stockpiles of medical countermeasures against smallpox: Benefits, risks, and knowledge gaps. Am. J Disaster Med. 2015; 10: 109-120.

Tucker JB: Breaking the deadlock over destruction of the smallpox virus stocks. Biosecur. Bioterror. 2011; 9: 55-67.

Fenner F: Can smallpox return? World Health Forum. 1987; 8: 297-304. Available at: http://apps.who.int/iris/handle/10665/49821. Accessed April 14, 2016.

Fenner F, Henderson DA, Arita I, et al: Potential sources for a return of smallpox. 1988, World Health Organization, Geneva. In: Smallpox and its eradication, chapter 30, 1321-1345. Available at: http://apps.who.int/iris/handle/10665/39485. Accessed April 14, 2016.

World Health Organization: WHO Advisory Committee on Variola Virus Research, report of the sixth meeting. 2004. Available at: http://www.who.int/csr/resources/publications/WHO_CDS_CSR_ARO_2005_4/en/. Accessed April 14, 2016.

Scientific review of variola virus research, 1999-2010. World Health Organisation. 2010. Available at: http://whqlibdoc.who.int/hq/2010/WHO_HSE_GAR_BDP_2010.3_eng.pdf. Accessed April 14, 2016.

Paté-Cornell E, Guikema S: Probabilistic Modeling of Terrorist Threats: A Systems Analysis Approach to Setting Priorities Among Countermeasures. Military Operations Research. 2002; 7: 5-20. Available at: http://onlinepubs.trb.org/onlinepubs/archive/conferences/MB/PateCornellPaper.pdf Accessed April 14, 2016.

Committee on Methodological Improvements to the Department of Homeland Security’s Biological Agent Risk Analysis, US National Research Council: Department of Homeland Security Bioterrorism Risk Assessment: A Call for Change. 2008. Available at: http://www.nap.edu/catalog/12206/department-of-homelandsecurity-bioterrorism-risk-assessment-a-call-for. Accessed April 14, 2016.

Gryphon Scientific: Risk and Benefit Analysis of Gain of Function Research. Draft Final Report. December 2015. Available at: http://www.gryphonscientific.com/wp-content/uploads/2015/12/Final-Gain-of-Function-Risk-Benefit-Analysis-Report-12.14.2015.pdf. Accessed April 14, 2016.

Rotz LD, Khan AS, Lillibridge SR, et al: Public health assessment of potential biological terrorism agents. Emerg. Infect. Dis. 2002; 8: 225230.

MacIntyre CR, Seccull A, Lane JM, et al: Development of a risk-priority score for category A bioterrorism agents as an aid for public health policy. Mil Med. 2006; 171: 589-594.

Tomuzia K, Menrath A, Frentzel H, et al: Development of a comparative risk ranking system for agents posing a bioterrorism threat to human or animal populations. Biosecur. Bioterror. 2013; 11: Suppl 1, S3-S16.

Boddie C, Watson M, Ackerman G, et al: BIOSECURITY. Assessing the bioweapons threat. Science. 2015; 349: 792793.

Ezell BC, Bennett SP, von Winterfeldt D, et al: Probabilistic risk analysis and terrorism risk. Risk Anal. 2010; 30: 575-589.

National Science Advisory Board for Biosecurity: Working Paper Prepared by the NSABB Working Group on Evaluating the Risks and Benefits of Gain-of-Function Studies to Formulate Policy Recommendations. Deliberative draft. December 23, 2015. Available at: http://osp.od.nih.gov/office-biotechnology-activities/event/2016-01-07-130000-2016-01-08-220000/national-scienceadvisory-board-biosecurity-nsabb-meeting. Accessed April 14, 2016.

Meltzer MI: Risks and benefits of preexposure and postexposure smallpox vaccination. Emerg. Infect. Dis. 2003; 9: 1363-1370.

Banks DL, Anderson S: Combining Game Theory and Risk Analysis in Counterterrorism: A Smallpox Example. 2008. In: Department of Homeland Security Bioterrorism Risk Assessment: A Call for Change. Appendix F. Available at: http://www.nap.edu/catalog/12206/department-of-homeland-securitybioterrorism-risk-assessment-a-call-for. Accessed April 14, 2016.

German Federal Office of Civil Protection and Disaster Assistance: Method of Risk Analysis for Civil Protection. 2011. Available at: http://www.bbk.bund.de/SharedDocs/Downloads/BBK/EN/booklets_leaflets/Method_of_%20Risk_Analysis.pdf?__blob=publicationFile. Accessed April 14, 2016.

Petersen BW, Damon IK, Pertowski CA, et al: Clinical Guidance for Smallpox Vaccine Use in a Postevent Vaccination Program. MMWR Recomm. Rep. 2015; 64(RR-02): 1-26.

World Health Organization: WHO Strategic Advisory Group of Experts (SAGE) report, consultation on smallpox vaccines, final draft. 17 October 2013. Available at: http://www.who.int/immunization/sage/meetings/2013/november/1_SAGE_report_consultation_smallpox.pdf. Accessed April 14, 2016.

European Medicines Agency, Public Assessment Report, Imvanex. 2013. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_ report/human/002596/WC500147898.pdf. Accessed April 14, 2016.




DOI: http://dx.doi.org/10.5055/ajdm.2015.0218

Refbacks

  • There are currently no refbacks.